The following question is for the Ask Dr Barken
Call In Show on Tuesday, Jan. 17th at 6pm Pacific
Time. Dial 1-877-727-3301 to hear the program.
Question of the week:
What is the difference between hormone-insensitive,
hormone-refractory, hormone-independent and
castration-resistant prostate cancer?
Dr. Barken answers this question and introduces
a video lecture about the subject.
Video Lecture:
Charles Drake, M.D. of Johns Hopkins discusses new
drugs in the pipeline for prostate cancer. This presentation
took place at the annual Prostate Cancer Research Institute
public conference 2011.
Article:
MDV3100 for the treatment of prostate cancer.
De-Bono JS., Expert Opin Investig Drugs. 2012 Jan 10
You must log in to post a comment.